Literature DB >> 6219604

Adverse effects of new cephalosporins.

S G Jenkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6219604     DOI： 10.7326/0003-4819-98-3-415_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Platelet function and coagulation in patients with hepatobiliary disorders receiving cefotetan prophylaxis.

Authors:  D R Triger; R G Malia; F E Preston
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

2.  Effects of antibiotics on platelet aggregation.

Authors:  K Sunakawa; H Akita; S Iwata; Y Sato; T Oikawa; Y Ichihashi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  The great cephalosporin wars.

Authors:  M S Cohen
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

Review 4.  Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Authors:  G L Kearns; R A Young
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

5.  Nephrotoxic potential of first-, second-, and third-generation cephalosporins.

Authors:  C Cojocel; U Göttsche; K L Tölle; K Baumann
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 6.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.